CBS 11 Header TXA 21 Header MeTV Header KRLD Header The Fan Header
CBS DFW WEATHER APP: iPhone App Store | Android App Coming Soon | More Information

News

FDA Approves Meningitis Vaccine For Infants

View Comments

CBS DFW (con't)

Affordable Care Act Updates: CBSDFW.com/ACA

Health News & Information: CBSDFW.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

From Our CBS Music Web Sites

625x352 thrill eng preview FDA Approves Meningitis Vaccine For InfantsWin A Trip To Disneyland!

82641739 10 FDA Approves Meningitis Vaccine For InfantsHottest Sunbathers Of The Summer

jennifer lopez 770 FDA Approves Meningitis Vaccine For InfantsJennifer Lopez's Bathtub Selfie

 alt=The New Wonder Woman

 alt=Musicians Then And Now

Fantasy_tile

VOTE: Best Coaches In American Sports

NEW YORK (CBS NEWS) - A new combination vaccine that protects infants from two deadly infections that can cause meningitis, meningococcal disease and Hib disease, was approved Thursday by the U.S. Food and Drug Administration.

The vaccine, called Menhibrix, has been approved for children ages 6 weeks through 18 months old. It’s given as a four-dose series at 2, 4, 6 and 12 through 15 months of age, and the first dose may be given as early as 6 weeks of age. It is manufactured by GlaxoSmithKline.

Meningococcal disease is caused by the bacteria Neisseria meningitides, and is most commonly diagnosed among infants, adolescents and young adults. A common outcome of the infection is meningitis, a life-threatening infection of the covering that surrounds the brain and spinal cord. About 1,000 causes of meningococcal disease occur each year.

The bacteria spreads through respiratory and throat secretions like spit, but aren’t as contagious as the common cold or flu. Infants with meningococcal meningitis may appear to be slow or inactive, irritable, vomiting or feeding poorly, according to the Centers for Disease Control and Prevention.

Click Here To Read More From CBS News

Also Check Out:

View Comments